Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cardiology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cardiology Other
    The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials - (BMJ)
    FDA Approves Dronedarone for Atrial Fibrillation or Atrial Flutter - (DGNews)
    Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease - (JAMA)
    Novel and conventional biomarkers for prediction of incident cardiovascular events in the community - (JAMA)
    Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study - (BMJ)

    News archive

     Recent webcasts/CME - Cardiology Other
    • State of the Science in Managing the Treatment-Experienced Patient With HIV
    • What's New in Managing Treatment-Experienced Patients With HIV?
    • Applying Data to Practice: Case Vignettes
    • Rheumatoid Arthritis: The Heart of the Matter Assessing Cardiovascular Risk in Patients with Rheumatoid Arthritis
      Supraventricular Tachycardia in Children and Adolescents

      Webcasts/CME archive

       Recent cases - Cardiology Other
        Cardiogenic Shock Caused by Disulfiram
        Congenital Atresia of the Left Main Coronary Artery Associated With Patent Ductus Arteriosus and Aortic Regurgitation
        Pleural Effusion and Pulmonary Hypertension in a Patient With Parkinson Disease Treated With Cabergoline
        A Well-Circumscribed Density Along the Right Heart Border
        A Case of Massive Pulmonary Embolism with ST Elevation in Leads V1-4

        Cases archive
          




        my personal edition > cardiology other > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Vitamin D Deficiency Increases Risk of Cardiovascular Disease

          WASHINGTON, DC -- December 10, 2008 -- Vitamin D deficiency, which is traditionally associated with bone and muscle weakness, may also increase the risk of cardiovascular disease (CVD), according to a review article published in the December 9 issue of the Journal of the American College of Cardiology.

          The authors issue practical recommendations to screen for and treat low vitamin D levels, especially in patients with risk factors for heart disease or diabetes.

          "Vitamin D deficiency is an unrecognised, emerging cardiovascular risk factor, which should be screened for and treated," said James H. O'Keefe, MD, Preventive Cardiology at the Mid America Heart Institute, Kansas City, Missouri. "Vitamin D is easy to assess, and supplementation is simple, safe, and inexpensive."

          Recent data from the Framingham Heart Study suggest patients with vitamin D levels below 15 ng/mL were twice as likely to experience a heart attack, stroke, or other CV event within the next 5 years compared with those with higher levels. This risk remained even when researchers adjusted for traditional CV risk factors.

          "Restoring vitamin D levels to normal is important in maintaining good musculoskeletal health, and it may also improve heart health and prognosis," said Dr. O'Keefe. "We need large randomised controlled trials to determine whether or not vitamin D supplementation can actually reduce future heart disease and deaths."

          In the absence of clinical guidelines, the authors outline specific recommendations for restoring and maintaining optimal vitamin D levels in CV patients. These patients should initially be treated with 50,000 IU of vitamin D2 or D3 once weekly for 8 to 12 weeks. Maintenance therapy should be continued using one of the following strategies:
          · 50,000 IU vitamin D2 or D3 every 2 weeks
          · 1,000 to 2,000 IU vitamin D3 daily
          · Sunlight exposure for 10 minutes for white patients (longer for people with increased skin pigmentation) between the hours of 10:00 AM to 3:00 PM

          SOURCE: American College of Cardiology




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send